Zhitong Finance App News, Fosun Pharmaceutical (600196.SH) announced that on September 4, 2026, India time, Fosun Pharma Singapore, the company's holding subsidiary, sold a total of 9.897 million Gland Pharma shares through bulk transactions and centralized bidding (accounting for about 6.00% of the total number of Gland Pharma shares as of September 3, 2026). The total transaction consideration (before deducting transaction fees and taxes) was 27.996 billion Indian rupees (discounted contract of US$294 million), average price (before transaction fee and taxes) Approximately INR 2,828.78 per share (before commissions and taxes), a discount of about 2.72% from the closing price of the previous trading day (i.e. INR 2,907.90). The expected share transfer time for this transaction is September 7, 2026, India time.

Zhitongcaijing · 2d ago
Zhitong Finance App News, Fosun Pharmaceutical (600196.SH) announced that on September 4, 2026, India time, Fosun Pharma Singapore, the company's holding subsidiary, sold a total of 9.897 million Gland Pharma shares through bulk transactions and centralized bidding (accounting for about 6.00% of the total number of Gland Pharma shares as of September 3, 2026). The total transaction consideration (before deducting transaction fees and taxes) was 27.996 billion Indian rupees (discounted contract of US$294 million), average price (before transaction fee and taxes) Approximately INR 2,828.78 per share (before commissions and taxes), a discount of about 2.72% from the closing price of the previous trading day (i.e. INR 2,907.90). The expected share transfer time for this transaction is September 7, 2026, India time.